Inventor · disambiguated record
Stuart F. Schlossman
Also filed as: SCHLOSSMAN STUART · SCHLOSSMAN STUART F · SCHLOSSMAN STUART FRANKLIN
27 granted patents·704 citations·filing 1982–2007
97Inventor score
Top patents by PatentIndex Score
27 records- 0193US4550086AMonoclonal antibodies that recognize human T cellsDANA FARBER CANCER INST INC·Filed 1983·Granted Oct 29, 1985·61 cites·13 claims
- 0290US5019648AMonoclonal antibody specific for the adhesion function domain of a phagocyte cell surface proteinDANA FARBER CANCER INST INC·Filed 1988·Granted May 28, 1991·82 cites·9 claims
- 0390US5002869AMonoclonal antibody specific to a novel epitope of the LFA-1 antigen of human T lymphocytesDANA FARBER CANCER INST INC·Filed 1987·Granted Mar 26, 1991·37 cites·22 claims
- 0487US4840793AMethod of reducing tissue damage at an inflammatory site using a monoclonal antibodyDANA FARBER CANCER INST INC·Filed 1987·Granted Jun 20, 1989·113 cites·11 claims
- 0585US4443427AMonoclonal antibodyFARBER SIDNEY CANCER INST·Filed 1982·Granted Apr 17, 1984·53 cites·8 claims
- 0682US6265551B1Form of dipeptidylpeptidase IV (CD26) found in human serum, antibodies thereto, and uses thereofDANA FARBER CANCER INST INC·Filed 1996·Granted Jul 24, 2001·60 cites·15 claims
- 0778US7658923B2Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing CD26UNIV TEXAS·Filed 2007·Granted Feb 9, 2010·4 cites·32 claims
- 0873US7198788B2Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing CD26.DANA FARBER CANCER INST INC·Filed 2002·Granted Apr 3, 2007·7 cites·35 claims
- 0973US6325989B1Form of dipeptidylpeptidase IV (CD26) found in human serumDANA FARBER CANCER INST INC·Filed 1995·Granted Dec 4, 2001·44 cites·13 claims
- 1073US5120642AMonoclonal antibody which distinguishes helper inducer and suppressor inducer cd4+ lymphocytesCOULTER CORP·Filed 1989·Granted Jun 9, 1992·31 cites·21 claims
- 1170US6010853ASiva genes, novel genes involved in CD27-mediated apoptosisDANA FARBER CANCER INST INC·Filed 1997·Granted Jan 4, 2000·44 cites·16 claims
- 1270US5219997AMonoclonal antibody which inhibits the adhesion functions of the β integrin, CR3DANA FARBER CANCER INST INC·Filed 1991·Granted Jun 15, 1993·27 cites·1 claims
- 1364US5935801AMonoclonal antibody that detects apoptotic antigenDANA FARBER CANCER INST INC·Filed 1996·Granted Aug 10, 1999·14 cites·8 claims
- 1464US4882424AActivation antigenDANA FARBER CANCER INST INC·Filed 1987·Granted Nov 21, 1989·12 cites·5 claims
- 1561US4772552AMonoclonal antibody which recognizes a 200-220 KD antigen on natural killer cellsDANA FARBER CANCER INST INC·Filed 1984·Granted Sep 20, 1988·8 cites·14 claims
- 1655US5250431AAlteration of the interaction of a T-cell receptor with a proteintyrosine kinaseDANA FARBER CANCER INST INC·Filed 1991·Granted Oct 5, 1993·20 cites·18 claims
- 1754US5843635AInhibition of APC-mediated apoptosis of activated T lymphocytesDANA FARBER CANCER INST INC·Filed 1995·Granted Dec 1, 1998·24 cites·8 claims
- 1853US5298407ADNA encoding a protein active in lymphocyte-mediated cytotoxicityDANA FARBER CANCER INST INC·Filed 1991·Granted Mar 29, 1994·9 cites·15 claims
- 1953US4987084AMethod of testing the effect of a molecule on B lymphocyte functionDANA FARBER CANCER INST INC·Filed 1989·Granted Jan 22, 1991·14 cites·8 claims
- 2051US5340935ADNAS encoding proteins active in lymphocyte-medicated cytotoxicityDANA FARBER CANCER INST INC·Filed 1992·Granted Aug 23, 1994·8 cites·7 claims
- 2147US4661446AMonoclonal antibodies and method of immunizing therewithDANA FARBER CANCER INST INC·Filed 1985·Granted Apr 28, 1987·6 cites·6 claims
- 2244US6933132B1Regulation of immune responses by attractinDANA FARBER CANCER INST INC·Filed 1999·Granted Aug 23, 2005·5 cites·46 claims
- 2344US5079343AIntracellular antigen found in subpopulation of cd8+ t lymphocytes and monoclonal antibody reactive with sameDANA FARBER CANCER INST INC·Filed 1990·Granted Jan 7, 1992·5 cites·2 claims
- 2444US4692405AMonoclonal antibodies to antigen on activated human B-cells and assay therefor, protein antigenic determinant therefor and method of making sameDANA FARBER CANCER INST INC·Filed 1985·Granted Sep 8, 1987·10 cites·22 claims
- 2537US5432076AAlteration of the interaction of a T-cell receptor with a protein-tyrosine kinaseDANA FARBER CANCER INST INC·Filed 1993·Granted Jul 11, 1995·3 cites·5 claims
- 2633US4649106ADistinguishing subsets of human cellsDANA FARBER CANCER INST INC·Filed 1984·Granted Mar 10, 1987·3 cites·7 claims
- 2731US5837811AProteins active in lymphocyte-mediated cytotoxicityDANA FARBER CANCER INST INC·Filed 1994·Granted Nov 17, 1998·0 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when Stuart F. Schlossman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →